Enables somatostatin receptor activity. Involved in several processes, including cellular response to glucocorticoid stimulus; positive regulation of arachidonate secretion; and regulation of signal transduction. Predicted to be active in neuron projection and plasma membrane. Biomarker of status epilepticus. Orthologous to human SSTR4 (somatostatin receptor 4); PARTICIPATES IN cimetidine pharmacodynamics pathway; esomeprazole pharmacodynamics pathway; famotidine pharmacodynamics pathway; INTERACTS WITH (+)-pilocarpine; 6-propyl-2-thiouracil; acrylamide.
SSTR4 gene mutant form promotes the reaction [Oxazolone results in increased expression of IL1B protein] and SSTR4 gene mutant form promotes the reaction [Oxazolone results in increased expression of TNF protein]
SSTR4 gene mutant form promotes the reaction [Lipopolysaccharides results in increased expression of IFNG protein] and SSTR4 gene mutant form promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein]
Functional coupling of SSTR4, a major hippocampal somatostatin receptor, to adenylate cyclase inhibition, arachidonate release and activation of the mitogen-activated protein kinase cascade.
Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
Expression of the five somatostatin receptor (SSTR1-5) subtypes in rat pituitary somatotrophes: quantitative analysis by double-layer immunofluorescence confocal microscopy.
Role of glucocorticoids in the regulation of pituitary somatostatin receptor subtype (sst1-sst5) mRNA levels: evidence for direct and somatostatin-mediated effects.